Northwest Biotherapeutics (NWBO) Gross Profit (2010 - 2013)

Northwest Biotherapeutics' Gross Profit history runs 4 years deep, the most recent figure standing at $400000.0 for Q3 2013.

• In Q3 2013, Gross Profit changed N/A year-over-year to $400000.0; the TTM figure through Mar 2014 stood at $672000.0 (up 314.7% YoY), while the FY2013 annual figure was $809000.0, changed N/A from the prior year.
• Gross Profit for Q3 2013 stood at $400000.0, up from $272000.0 in the prior quarter.
• The five-year high for Gross Profit was $400000.0 in Q3 2013, with the low at -$450000.0 in Q4 2012.
• The 4-year median for Gross Profit is $73500.0 (2010), against an average of $63166.7.
• Peak annual rise in Gross Profit reached 0.0% in 2011, while the deepest fall reached 0.0% in 2011.
• Northwest Biotherapeutics' Gross Profit stood at $10000.0 in 2010, then changed by 0.0% to $10000.0 in 2011, then tumbled by 4600.0% to -$450000.0 in 2012, then surged by 188.89% to $400000.0 in 2013.
• Business Quant data shows NWBO's Gross Profit at $400000.0 in Q3 2013, $272000.0 in Q2 2013, and $137000.0 in Q1 2013.